| Kristopher Tkatch, DO | |
|
320 E North Ave, Pittsburgh, PA 15212-4756 | |
| (412) 359-4905 | |
| Not Available |
| Full Name | Kristopher Tkatch |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 6 Years |
| Location | 320 E North Ave, Pittsburgh, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013413574 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 309620 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Faxton-st Luke's Healthcare | Utica, NY | Hospital |
| St Elizabeth Medical Center | Utica, NY | Hospital |
| St Joseph's Hospital Health Center | Syracuse, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Manning Emergency Medical Associates Pllc | 0244397271 | 18 |
| Emergency Physician Services Of New York, P.c. | 8325939804 | 92 |
News Archive
Living Cell Technologies Limited today announced results from a Phase I/IIa clinical study of NTCELL, an experimental regenerative cell therapy being studied as a disease-modifying agent in Parkinson's disease. The study, conducted in four patients in New Zealand, met its primary endpoint of safety, showing NTCELL implantation was well tolerated, with no adverse events considered to be related to NTCELL.
The Melting Pot Restaurants, Inc., the world's premier fondue restaurant franchise, is partnering with St. Jude Children's Research Hospital for the 10th annual St. Jude Thanks and Giving campaign from Oct. 19 - Dec. 15, that asks guests to "give to help the children of St. Jude live" by raising funds for cancer research.
GnuBIO, a privately-held life sciences company that has developed a droplet-based DNA sequencing technology, today announced that it was acquired by Bio-Rad Laboratories, Inc. With this acquisition, Bio-Rad will expand its Digital Biology Center and establish a research and development site in Cambridge, Massachusetts.
A live-attenuated vaccine against the four strains of dengue virus known as CYD-TDV has demonstrated promising efficacy in a phase IIb trial.
› Verified 9 days ago
| Entity Name | Emergency Physician Services Of New York, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093759847 PECOS PAC ID: 8325939804 Enrollment ID: O20041001000684 |
News Archive
Living Cell Technologies Limited today announced results from a Phase I/IIa clinical study of NTCELL, an experimental regenerative cell therapy being studied as a disease-modifying agent in Parkinson's disease. The study, conducted in four patients in New Zealand, met its primary endpoint of safety, showing NTCELL implantation was well tolerated, with no adverse events considered to be related to NTCELL.
The Melting Pot Restaurants, Inc., the world's premier fondue restaurant franchise, is partnering with St. Jude Children's Research Hospital for the 10th annual St. Jude Thanks and Giving campaign from Oct. 19 - Dec. 15, that asks guests to "give to help the children of St. Jude live" by raising funds for cancer research.
GnuBIO, a privately-held life sciences company that has developed a droplet-based DNA sequencing technology, today announced that it was acquired by Bio-Rad Laboratories, Inc. With this acquisition, Bio-Rad will expand its Digital Biology Center and establish a research and development site in Cambridge, Massachusetts.
A live-attenuated vaccine against the four strains of dengue virus known as CYD-TDV has demonstrated promising efficacy in a phase IIb trial.
› Verified 9 days ago
| Entity Name | Manning Emergency Medical Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720232721 PECOS PAC ID: 0244397271 Enrollment ID: O20090319000059 |
News Archive
Living Cell Technologies Limited today announced results from a Phase I/IIa clinical study of NTCELL, an experimental regenerative cell therapy being studied as a disease-modifying agent in Parkinson's disease. The study, conducted in four patients in New Zealand, met its primary endpoint of safety, showing NTCELL implantation was well tolerated, with no adverse events considered to be related to NTCELL.
The Melting Pot Restaurants, Inc., the world's premier fondue restaurant franchise, is partnering with St. Jude Children's Research Hospital for the 10th annual St. Jude Thanks and Giving campaign from Oct. 19 - Dec. 15, that asks guests to "give to help the children of St. Jude live" by raising funds for cancer research.
GnuBIO, a privately-held life sciences company that has developed a droplet-based DNA sequencing technology, today announced that it was acquired by Bio-Rad Laboratories, Inc. With this acquisition, Bio-Rad will expand its Digital Biology Center and establish a research and development site in Cambridge, Massachusetts.
A live-attenuated vaccine against the four strains of dengue virus known as CYD-TDV has demonstrated promising efficacy in a phase IIb trial.
› Verified 9 days ago
| Entity Name | Physicians Medical Associates New York Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073386421 PECOS PAC ID: 7618310368 Enrollment ID: O20240209000066 |
News Archive
Living Cell Technologies Limited today announced results from a Phase I/IIa clinical study of NTCELL, an experimental regenerative cell therapy being studied as a disease-modifying agent in Parkinson's disease. The study, conducted in four patients in New Zealand, met its primary endpoint of safety, showing NTCELL implantation was well tolerated, with no adverse events considered to be related to NTCELL.
The Melting Pot Restaurants, Inc., the world's premier fondue restaurant franchise, is partnering with St. Jude Children's Research Hospital for the 10th annual St. Jude Thanks and Giving campaign from Oct. 19 - Dec. 15, that asks guests to "give to help the children of St. Jude live" by raising funds for cancer research.
GnuBIO, a privately-held life sciences company that has developed a droplet-based DNA sequencing technology, today announced that it was acquired by Bio-Rad Laboratories, Inc. With this acquisition, Bio-Rad will expand its Digital Biology Center and establish a research and development site in Cambridge, Massachusetts.
A live-attenuated vaccine against the four strains of dengue virus known as CYD-TDV has demonstrated promising efficacy in a phase IIb trial.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kristopher Tkatch, DO 2211 Sarah St Apt 1, Pittsburgh, PA 15203-2224 Ph: (330) 565-4121 | Kristopher Tkatch, DO 320 E North Ave, Pittsburgh, PA 15212-4756 Ph: (412) 359-4905 |
News Archive
Living Cell Technologies Limited today announced results from a Phase I/IIa clinical study of NTCELL, an experimental regenerative cell therapy being studied as a disease-modifying agent in Parkinson's disease. The study, conducted in four patients in New Zealand, met its primary endpoint of safety, showing NTCELL implantation was well tolerated, with no adverse events considered to be related to NTCELL.
The Melting Pot Restaurants, Inc., the world's premier fondue restaurant franchise, is partnering with St. Jude Children's Research Hospital for the 10th annual St. Jude Thanks and Giving campaign from Oct. 19 - Dec. 15, that asks guests to "give to help the children of St. Jude live" by raising funds for cancer research.
GnuBIO, a privately-held life sciences company that has developed a droplet-based DNA sequencing technology, today announced that it was acquired by Bio-Rad Laboratories, Inc. With this acquisition, Bio-Rad will expand its Digital Biology Center and establish a research and development site in Cambridge, Massachusetts.
A live-attenuated vaccine against the four strains of dengue virus known as CYD-TDV has demonstrated promising efficacy in a phase IIb trial.
› Verified 9 days ago
Dr. Andrew Jerome Coyle, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 Bower Hill Rd, Pittsburgh, PA 15243 Phone: 412-942-4000 | |
Dr. Josef Turner, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 320 E North Ave, Emergency Medicine Residency Office, Pittsburgh, PA 15212 Phone: 412-359-4905 | |
Dr. Vincent Samuel Ceretto, D.O Emergency Medicine Medicare: Medicare Enrolled Practice Location: 320 E North Ave, Pittsburgh, PA 15212 Phone: 412-359-3030 Fax: 412-359-3060 | |
Anna Moseley Vanatta, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 320 E North Ave, Pittsburgh, PA 15212 Phone: 412-359-4905 | |
Mackenzie Marie Mcgahan, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 320 E North Ave, Pittsburgh, PA 15212 Phone: 412-359-4905 | |
Michael Turturro, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1400 Locust St, Pittsburgh, PA 15219 Phone: 412-232-8381 | |
Arvind Venkat, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 320 E North Ave, Pittsburgh, PA 15212 Phone: 412-359-6180 Fax: 412-359-8874 |